Diligence memo · auto-generated · as of July 2, 2026
GenoTwin, Inc.
GenoTwin, Inc. looks under-valued against its niche peers and is dormant on financing cadence.
Businessfiled
GenoTwin, Inc. operates in Other Health Care, based in BRIDGEWATER.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
GenoTwin, Inc. has raised $200K in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $200K on 2020-12-01.
Most recent recorded round closed around 2020-12-01.
Valuation (modeled)modeled
Provath models GenoTwin, Inc. at approximately $5.0M (range $125K–$50M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.62× the median modeled value of Pre-Seed Other Health Care companies in 2019–2021 (295 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Last raise 5.6 yr ago; this sector typically re-raises about every 14 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 9% of Other Health Care peers (5377 compared).
Modeled value ranks above 21% of those peers.
Closest niche peers: Aetas Co LLC, Hauppauge SC Holdings, LLC, Gateway IV Lithotripsy, LLC, Endoscopy Center of West Central Ohio, LLC, Dalent LLC.
Peoplefiled
4 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.